The Co-Delivery of Natural Products and Small RNAs for Cancer Therapy: A Review

The Co-Delivery of Natural Products and Small RNAs for Cancer Therapy: A Review

Blog Article

This review summarizes the research progress in the co-delivery of natural products (NPs) and small RNAs in cancer therapy.NPs such as paclitaxel, camptothecin, and curcumin possess multi-target antitumor effects, but their applications are limited by drug resistance and non-specific distribution.Small RNAs can achieve precise antitumor effects through gene regulation, yet their delivery efficiency is low, and they are prone Desktop Vaporizers to degradation by nucleases.

Nanomaterial-based drug delivery systems (nano-DDSs) provide an efficient platform for the co-delivery of both, which can enhance the helmets targeting of their delivery and improve the synergistic antitumor effects simultaneously.The mechanisms of the antitumor action of natural compounds and small RNAs, the design and application of nanocarriers, and the latest research progress in co-delivery systems are introduced in detail in this paper.The application prospects of the co-delivery of natural compounds and small RNAs in cancer therapy are also discussed.